Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
330.7 USD | +0.05% | +0.11% | +73.56% |
May. 06 | Shockwave Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 63.28 and 53.79 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+73.46% | 12.41B | B- | ||
-16.75% | 8.12B | C+ | ||
+5.93% | 6.59B | C- | ||
-4.73% | 5.83B | B | ||
+13.79% | 5.46B | D+ | ||
+40.99% | 5.05B | - | ||
-19.05% | 4.02B | B- | ||
-34.55% | 2.47B | C | ||
-0.99% | 2.02B | - | ||
+4.94% | 1.89B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SWAV Stock
- Ratings Shockwave Medical, Inc.